PROFILE |
 |
Holy cow! Pharming Group develops pharmaceuticals from the milk of transgenic animals. Cattle, mice, and rabbits carrying an extra human gene produce high levels of human lactoferrin (hLF), a protein which is found naturally in mother's milk and has various immunological properties; hLF can then be used to create drugs. The firm is also producing alpha-Glucosidase transgenically; it is developing the protein, its lead drug candidate, to treat Pompe's disease. Other targets include rheumatoid arthritis, infections, cardiovascular disease, and trauma. Pharming has development partnerships with such companies as Genzyme (which accounts for more than half its revenues), Baxter, and XTL Biopharmaceuticals.
COMPETITION |
 |
Genzyme Transgenics Corporation (GZTC)
ImmuCell Corporation (ICCC)
PPL Therapeutics plc (PPL)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 17.40
1-Yr. Sales Growth: 38.5%
Employees: 208
Revenue per employee: $83,653.85
KEY PEOPLE |
 |
George J.M. Hersbach
CEO
Ino H.M. Cooijmans
CFO
CONTACT INFO |
 |
2333 CA Leiden
, The Netherlands
Phone: 31-71-524-74-00
Fax: 31-71-521-65-07
Online: Web Site
|